These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 707155)
61. [Decomposition of salicylamide glycosides in alkaline & acid media. VIII. Phenol glycoside]. WAGNER G Pharm Zentralhalle Dtschl; 1957; 96(8-9):488-95. PubMed ID: 13484409 [No Abstract] [Full Text] [Related]
62. Change of dissolution rate profile of salicylamide in caffeine complexing medium [proceedings]. Donbrow M; Touitou E J Pharm Pharmacol; 1976 Dec; 28 Suppl():4P. PubMed ID: 12315 [No Abstract] [Full Text] [Related]
63. Instrumental approaches to particle-counting in pharmaceutical liquids. Appino JB; Robinson RU Ann N Y Acad Sci; 1969 Jun; 158(3):680-9. PubMed ID: 5257929 [No Abstract] [Full Text] [Related]
64. [Decomposition and stabilization of drugs. 8. Reaction products of norphenylephrine with degradation products of sugars]. Kigazawa K; Ikari N; Okubo K; Imura H; Haga S Yakugaku Zasshi; 1973 Jul; 93(7):925-7. PubMed ID: 4738544 [No Abstract] [Full Text] [Related]
65. Multiregressional analysis of the Griffin HLB numbers for polyoxyethylene polyoxypropylene surfactants. Lowenthal W J Pharm Sci; 1968 Mar; 57(3):514-5. PubMed ID: 5655597 [No Abstract] [Full Text] [Related]
66. [Separation and identification of components of drugs containing salicylamide by means of paper chromatography]. Fecko J; Przybylek-Piontek W Acta Pol Pharm; 1968; 25(2):177-81. PubMed ID: 5662910 [No Abstract] [Full Text] [Related]
67. [Analysis of the products of drug decomposition. XLII. Determining the levels of vitamin K in pharmaceutical preparations in the presence of decomposition products]. Marciniec B; Stachowicz M Acta Pol Pharm; 1989; 46(2):138-45. PubMed ID: 2631567 [TBL] [Abstract][Full Text] [Related]
68. Spectrophotometric analysis of mixtures of acetaminophen, salicylamide, and codeine phosphate in tablets. el Kheir AA; Belal SF; el Shanwani A J Assoc Off Anal Chem; 1985; 68(5):1048-50. PubMed ID: 4055623 [TBL] [Abstract][Full Text] [Related]
69. [Kinetics of drug degradation. VI. Kinetics of degradation of phenylbutazone (FB) in suppository bases]. Pawelczyk E; Zajac M Acta Pol Pharm; 1970; 27(2):113-7. PubMed ID: 5422244 [No Abstract] [Full Text] [Related]
70. [Kinetics of drug decomposition. III. Kinetics of decomposition of p-aminobenzoic acid and salicylamide in the presence of auxiliary tablet components]. Pawełczyk E; Wachowiak R Acta Pol Pharm; 1978; 35(4):433-9. PubMed ID: 707155 [No Abstract] [Full Text] [Related]
71. [Technical and present therapeutic aspects of tablet manufacture]. Jaminet F Pharm Acta Helv; 1968 Mar; 43(3):129-52. PubMed ID: 4888486 [No Abstract] [Full Text] [Related]